ISSN:
1432-0584
Keywords:
Key words Third malignancy
;
Myelodysplastic syndrome
;
Non-Hodgkin's lymphoma
;
Osteosarcoma
;
Alkylating agents
Source:
Springer Online Journal Archives 1860-2000
Topics:
Medicine
Notes:
Abstract The patient was initially diagnosed as having non-Hodgkin's lymphoma and was cured following treatment with prednisolone, vincristine, daunorubicin, l-asparaginase, and cyclophosphamide. Seven years and two months later, he developed osteosarcoma in his right femur. He received chemotherapy consisting of methotrexate, carboplatin, etoposide, and ifosfamide and again obtained remission. After 2 years and 7 months, however, he was found to have pancytopenia with morphological abnormalities in the erythroid and myeloid series. Diagnosis of myelodysplastic syndrome (MDS) was made. Cytogenetic analysis of bone marrow cells revealed -5 and -7, which is typical for secondary MDS. This is a rare case of third malignancy presumably caused by alkylating agents.
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1007/s002770050264
Permalink